Activation of the β 2 -adrenoceptor (β 2 -AR) elicits an endothelial nitric oxide synthase (eNOS)-dependent relaxation in mouse pulmonary artery, which, contrary to the muscarinic receptor-dependent relaxation, is preserved in hypoxic pulmonary arterial hypertension. We therefore characterized the signaling pathways underlying the β 2 -AR-mediated eNOS activation, with special focus on G i/o proteins, protein kinases and caveolae. Functional studies (for evaluation of vasorelaxant responses), Western blots (for assessment of eNOS and caveolin-1 phosphorylations) and transmission electron microscopy (for visualization of caveolae) were conducted in pulmonary arteries from wild-type or caveolin-1 knockout mice.
Introduction
Nitric oxide (NO), produced by the endothelial NO synthase (eNOS), is a major vasculoprotective agent owing to its vasodilator, anti-aggregant, anti-oxidant and antiproliferative properties [1] . Endothelial dysfunction, and particularly an impaired endothelial NO production and/or availability, plays a key role in many cardiovascular risk factors and diseases, including pulmonary arterial hypertension [2] . Pulmonary arterial hypertension is a severe disease, leading to right ventricular hypertrophy followed by right ventricular failure and ultimately death. The increase in pulmonary arterial resistances is the consequence of both structural remodelling and alterations of vasomotor responses, related to the imbalance between vasodilatator/antiproliferative and vasoconstrictor/proliferative factors [3] .
Restoration of NO production and/or availability in pulmonary arteries appears to be an interesting therapeutic approach to treat this disease.
As in other cardiovascular diseases, endothelial dysfunction in models of pulmonary arterial hypertension is established when pulmonary arteries exhibit a decrease in the relaxant response to acetylcholine, the reference endothelium-dependent vasodilator, acting through the activation of endothelial muscarinic receptors coupled to NO production [4, 5] . In a mouse model of chronic hypoxia-induced pulmonary arterial hypertension, we have shown that the relaxant response induced by the β 2 -AR stimulation, which is also endothelium-and eNOSdependent, is preserved, whereas the relaxant response to acetylcholine is decreased [5, 6] .
The preservation of this pulmonary endothelium-dependent β 2 -adrenergic vasorelaxation highlights the potential interest of the β 2 -AR as a therapeutic target in pulmonary arterial hypertension and suggests that the mechanisms underlying eNOS activation are determinant for expression of endothelial dysfunction in pulmonary arteries. Although β 2 -ARs have been described as endothelial β-ARs associated with a NO-dependent relaxant response in some systemic vascular beds [7] [8] [9] , there is limited information about the molecular mechanisms underlying the β 2 -adrenergic-mediated activation of eNOS.
The regulation of eNOS activity involves complex molecular mechanisms, including not only the calcium/calmodulin-dependent pathway, but also posttranslational mechanisms especially through modifications of eNOS phosphorylation and eNOS-protein interactions [10, 11] . In particular, caveolin-1, a major protein of endothelial caveolae, interacts with the inactive state of eNOS and the dissociation of this complex increases eNOS activity [12, 13] .
Whereas in mouse pulmonary arteries muscarinic-dependent activation of eNOS involves the M 3 subtype [14] , which is coupled to a G q /phospholipase C pathway and subsequent increase in cytosolic calcium concentration in endothelial cells, it is worth noting that the coupling mechanism between β 2 -AR and eNOS remains unknown in these arteries, except that it is independent of a cAMP/cAMP-dependent protein kinase (PKA) pathway [6] , suggesting that G s proteins are not recruited.
The aim of this study was therefore to identify the components of the signaling pathway involved in eNOS activation elicited by endothelial β 2 -AR stimulation and responsible for the β 2 -AR-mediated relaxation in the mouse pulmonary artery. Specifically, the following issues were addressed: (i) to evaluate the role of G i/o proteins in the β 2 -adrenergic relaxant response, as β 2 -ARs are known to couple not only to G s but also to G i/o proteins, in several tissues including cardiovascular ones [15, 16] ; (ii) to determine the effect of β 2 -AR stimulation on eNOS phosphorylation, at the key activating Ser 1177 residue of eNOS [17, 18] , and identify the protein kinases involved in eNOS phosphorylation; (iii) to investigate the role of caveolae and caveolin-1 in the mouse pulmonary β 2 -adrenergic relaxant response.
The contribution of these different signaling molecules to the pulmonary endothelial β 2 -AR-mediated activation of eNOS was investigated by using pharmacological tools and a genetic approach with caveolin-1 knockout mice (Cav-1 KO). In some experiments, the β 2 -adrenergic response was compared to the reference muscarinic relaxation which is also NOdependent [5] .
Material and Methods
The investigation is in accordance with the EC Directive 86/609/EEC on the ″Protection of animals used for experimental and other scientific purposes″. Agreement (number A 33409) was obtained from French authorities.
Reagents and antibodies
In the absence of indication, drugs were obtained from Left and right branches of the extralobar pulmonary artery were removed and cleaned of adventitial tissue [5] . These vessels were immediately used for functional and biochemical studies, except those used for the evaluation of the role of G i/o proteins, which were incubated in DMEM in the absence or presence of 400 ng/ml PTX for 12 hours at 37°C in a humidified atmosphere (95% air / 5% carbon dioxide).
Vascular reactivity studies
Segments of pulmonary arteries were mounted in a wire myograph (Multi Myograph System, model 610M, J.P. Trading, Aarhus, Denmark) to measure isometric tension, as previously described [5, 6] . Relaxant effects of 10 µM acetylcholine and 0.1 µM procaterol (in the presence of the α-adrenoceptor antagonist phentolamine, 10 µM) were studied in the same artery, after submaximal pre-contraction with PGF 2α . To characterize the signaling pathway 
Western blot
To evaluate the effect of Membranes were blocked overnight at 4°C. After incubation with the appropriate primary antibody, membranes were then incubated with the appropriate horseradish peroxidaseconjugated secondary antibody. Proteins were visualized using a chemiluminescence detection kit (Lumi-Light, Roche Diagnostics, Meylan, France).
Transmission Electronic Microscope Examination
Pulmonary arteries isolated from Cav-1 KO and WT mice were fixed with 2.5% glutaraldehyde in 0.1 M phosphate buffer for 2 hours at 4°C, post-fixed in 1% osmium tetroxide in 0.1 M phosphate buffer for 1 hour at room temperature, dehydrated through a series of graded ethanol and propylene oxide, and embedded in a mixture of propylene oxide and Epoxy resin (v/v) for 2 hours and then in 100% Epon resin. The resin was polymerized at 60°C for 48 hours. The samples were sectioned using a diamond knife on an ultra-microtome (Ultracut-E, Leica Microsystems). Thin sections (70 nm) were picked up on copper grids and then stained with uranyl acetate and lead citrate. The grids were examined with a transmission electron microscope at 120kV (Tecnai 12, FEI).
Statistical analysis
Data are given as mean ± S.E.M. of n experiments (n: number of mice). Different parameters were compared using Student's t-test for paired or unpaired data, where appropriate. A value of P<0.05 was considered significant.
Results

Role of G i/o proteins in the β 2 -AR-mediated relaxant response in mouse pulmonary artery
In a previous study, we have shown that in mouse pulmonary artery precontracted by PGF 2α , 0.1 µM procaterol (in the presence of phentolamine) induces a relaxation which is exclusively due to the endothelial β 2 -AR, eNOS and soluble guanylyl-cyclase stimulation [6] .
As shown in Figure 1 , a pretreatment of arteries with PTX, a G i/o protein inhibitor, significantly reduced the relaxation to procaterol without affecting the relaxation elicited by acetylcholine, the muscarinic agonist. This suggests that the β 2 -AR-mediated relaxant response involves activity of G i/o proteins.
Role of eNOS phosphorylation in the β 2 -AR-mediated relaxant response in mouse pulmonary artery
The phosphorylation status of eNOS is a critical determinant of its activity. As numerous kinases (including PI3K/Akt, PKA, AMPK, MAPK cascade, Src-kinase) may either directly or indirectly contribute to eNOS activation depending on the stimulus [10, 11] , we evaluated the effect of pharmacological inhibitors of these different pathways on the pulmonary β 2 -ARmediated relaxant response. Two PI3K inhibitors (wortmannin or LY 294002), the Akt inhibitor X and the Src-kinase inhibitor PP2 significantly decreased the amplitude of relaxation induced by procaterol in mice pulmonary arteries ( Fig. 2A, B (compound C) have no effect on this procaterol-mediated relaxant response ( Fig. 2A, C, E ).
This suggests that in mouse pulmonary arteries, PI3K/Akt and Src-kinase, but not ERK1/2, p38-MAPK, JNK or AMPK, pathways participate in the β 2 -adrenergic relaxation.
The PI3K/Akt pathway is known to directly phosphorylate the key Ser 1177 residue of eNOS, leading to its activation [17, 18] , whereas Src-kinase has been reported to act upstream of PI3K/Akt [19, 20] . We then determined the effect of 0.1 µM procaterol (in the presence of PGF 2α to mimic the experimental conditions of vascular reactivity studies) on eNOS phosphorylation at Ser 1177 in mouse pulmonary arteries. As shown in Figure 3A , stimulation of mouse pulmonary arteries with procaterol increased the phosphorylation of eNOS at Ser 1177 . This effect was observed after a 30 sec-incubation and further increased after 5 min to become statistically significant. Both Akt inhibitor X and PP2 abolished the effect of procaterol on the phosphorylation of eNOS at Ser 1177 (Fig. 3B) . In PTX-pretreated arteries, procaterol failed to modify eNOS phosphorylation at Ser 1177 (Fig. 3B ).
Role of caveolae and caveolin-1 in the β 2 -AR-mediated relaxant response in mouse pulmonary artery
To examine the role of caveolae in the β 2 -adrenergic-dependent relaxation, pulmonary arteries were incubated in the presence of methyl-β-cyclodextrin, a cholesterol-depleting agent that disrupts caveolae [21, 22] . As shown in Figure 4 , methyl-β-cyclodextrin treatment resulted in a 50% reduction of the procaterol-induced relaxation but had no significant effect on the endothelium-dependent relaxation to acetylcholine.
The role of caveolin-1, an essential structural protein of endothelial caveolae, was further addressed in pulmonary arteries isolated from Cav-1 KO mice. The loss of caveolin-1 protein expression in Cav-1 KO pulmonary arteries (Fig. 5A ) was associated with a disruption of caveolae at the endothelial cell membranes (Fig. 5B) . As illustrated in Figure 5C , the relaxation to procaterol was amplified and sustained in duration in Cav-1 KO compared to WT pulmonary arteries. On average, Cav-1 gene disruption increased the relaxant effect to procaterol by 179% in area (Fig. 5D ) and 39% in amplitude (Fig. 5E ) compared to WT pulmonary arteries. By contrast, the relaxant response to acetylcholine was similar in terms of amplitude and duration in WT and Cav-1 KO pulmonary arteries (Fig. 5D & E) . As in WT mice pulmonary arteries, both procaterol and acetylcholine-induced relaxations were markedly decreased by L-NAME, a NOS inhibitor, in Cav-1 KO mice pulmonary arteries (Fig. 5E) [23] . We therefore investigated the effect of β 2 -AR stimulation on caveolin-1 phosphorylation at this residue. Incubation of pulmonary arteries with procaterol caused a transient increase in caveolin-1 phosphorylation at Tyr 14 which was clearly seen at 30 sec- (Fig. 6 ) but disappeared at 5 min-incubation (data not shown). The level of caveolin-1 phosphorylation induced by a 30 sec-stimulation with procaterol was decreased by more than 50% not only in the presence of PP2, the Src-kinase inhibitor, but also in PTX-pretreated arteries (Fig. 6 ).
Discussion
Endothelial β 2 -AR stimulation elicits a NO-dependent relaxant response in both systemic [7] [8] [9] and pulmonary [6] vasculature. However, the molecular mechanisms involved in the coupling of β 2 -ARs to eNOS activation remained poorly understood. The present study depicts accurately the signaling cascade of the mouse pulmonary β 2 -AR. We report that the endothelial β 2 -adrenergic-mediated pulmonary relaxation involves a G i/o protein/Srckinase/PI3K/Akt pathway responsible for eNOS activation through its phosphorylation at the Ser 1177 residue. Interestingly, our results provide evidence for a tight control of this pathway by caveolin-1.
Historically, β 2 -ARs were classified as G s -protein coupled receptors. However, it is now widely recognized that β 2 -ARs can also efficiently couple to G i/o proteins. Our previous study demonstrated that the relaxation induced by β 2 -AR stimulation in mouse pulmonary artery is independent of the cAMP/PKA pathway [6] , which strongly argues against the involvement of G s proteins. In this study, we found that the mouse pulmonary β 2 -adrenergic vasorelaxant response was decreased by PTX, which is known to ADP-ribosylate G i/o proteins in arterial preparations [24] . The fact that PTX failed to alter the relaxant response to the muscarinic agonist acetylcholine, which likely involves activation of G q proteins, confirmed the specificity of PTX in our experimental conditions. Our results indicate that mouse pulmonary endothelial β 2 -AR couples to G i/o proteins to trigger the signaling cascade involved in NOdependent relaxation. PTX treatment decreased the β 2 -adrenergic response by only 50%. This [25] and in rat carotid artery [16] .
Phosphorylation of eNOS at the Ser 1177 residue is now recognized as a major mechanism of eNOS activation following diverse stimuli such as shear stress or receptor agonists [26] .
However, the effect of endothelial β 2 -AR stimulation on eNOS phosphorylation state has been little studied. In rat aorta and cultured HUVEC, β 2 -AR stimulation has been reported to increase the phosphorylation of eNOS at the Ser 1177 in a PKA-and PI3K/Akt-dependent manner [9, 25] . In this study, we found that in mouse pulmonary artery, β 2 -AR activation [9, 27, 28] or to the Src kinase pathway [16, 29] has been previously reported to participate in the β 2 -AR signaling in different cell types, including endothelial cells. However, in this study we show for the first time that both pathways contribute together to the β 2 -AR triggered eNOS phosphorylation and subsequent vasorelaxation. Our data suggest that, upon β 2 -AR activation, Akt is the kinase which directly phosphorylates eNOS at Ser 1177 , as widely recognized in different cell types [26] , whereas the Src tyrosine kinase likely acts upstream of PI3K/Akt, as clearly described in the endothelial estrogen receptor signaling cascade [19, 30] .
The fact that PTX, Src kinase inhibitor and Akt inhibitor abolished the β 2 -adrenergic effect on eNOS phosphorylation at Ser 1177 , but only partly reduced its vasorelaxant response, whereas this β 2 -adrenergic relaxant response has been shown to be totally eNOS-dependent [6] , suggests that other mechanism(s) than eNOS phosphorylation at Ser 1177 are involved in eNOS activation triggered by β 2 -AR stimulation in mouse pulmonary artery. Interestingly, we have shown that Src kinase and Akt inhibitors exert additive inhibitory effects on the β 2 -adrenergic relaxant response. Furthermore, Src kinase is known to exert a striking role in eNOS-dependent signaling related to its ability to directly phosphorylate caveolin-1 at Tyr 14 [23] and Src kinase-dependent phosphorylation of caveolin-1 has recently been proposed to promote caveolin-1 dissociation from eNOS, leading to eNOS activation and caveolaemediated endocytosis [31, 32] . In this context, we focused on the potential role of caveolin-1 in the additional mechanism responsible for β 2 -AR-dependent eNOS activation. Here, we reported for the first time that β 2 -AR stimulation induced a rapid and transient increase in caveolin-1 phosphorylation at Tyr 14 , which was reduced by PTX or Src kinase inhibitor. Thus, this suggests that in mouse pulmonary artery, the G i/o proteins/Src kinase pathway contributes to eNOS activation not only through its phosphorylation at Ser 1177 , but also through a caveolae-dependent mechanism. As the inhibitory effect of PTX and PP2 was only partial on the β 2 -AR-mediated caveolin-1 phosphorylation but total on the β 2 -AR-mediated eNOS phosphorylation, we can not exclude that another signaling pathway contributes to the increased caveolin-1 phosphorylation. This would deserve further investigation.
We therefore provided additional evidence for a role of caveolin-1 in the mouse pulmonary β 2 -AR-elicited relaxant response by using two different models of caveolae disruption.
Pharmacological disruption of caveolae by methyl-β-cyclodextrin, a cholesterol-binding agent [21] , decreased the β 2 -AR-mediated relaxant response, whereas the genetic disruption of caveolae, by using arteries isolated from Cav-1 KO mice, increased the β 2 -AR response, which was still Gi/o proteins-dependent, as shown by its inhibition in arteries treated with PTX, and eNOS-dependent, as shown by its abolition in the presence of the NOS inhibitor L-NAME. The apparent discrepancy in the vascular functional consequence of pharmacological or genetic caveolae disruption has been recently discussed [33] . According to these authors, caveolin-1 protein expression persists after methyl-β-cyclodextrin treatment, and acts as a scavenger of eNOS protein, inhibiting its activity, whereas in Cav-1 KO arteries, eNOS protein becomes free and more active. Our results are consistent with -and further supportthis model, as it is the first time, to our knowledge, that the effect of both pharmacological and genetic disruptions was investigated in parallel on a NO-dependent vasorelaxation in a given artery. This point is important because vasorelaxant responses studied in arteries isolated from Cav-1 KO mice have been shown to be decreased, increased or not modified, depending on the vasorelaxant agent or the vascular bed studied [32, [34] [35] [36] . Regarding the β 2 -AR-mediated vasorelaxation, Neidhold et al. reported that it was not modified in the saphenous artery from Cav-1 KO mouse [37] . However, the contribution of the endothelium to this relaxant response was not investigated and the authors assumed it to be smooth muscle-dependent. Thus, a major finding of our study is that endothelial caveolin-1 plays a key role in controlling the β 2 -AR-dependent activation of eNOS in mouse pulmonary artery, but is not required for β 2 -AR coupling to Gi/o proteins. Even if we can not conclude about the localization of β 2 -ARs in the pulmonary endothelial caveolae, the latter appear to be nonessential structures in the β 2 -AR signaling pathway, as suggested by data obtained in Cav-1 KO mice.
Contrary to the β 2 -AR-mediated response, the muscarinic receptor-mediated relaxation of mouse pulmonary arteries, which is also fully NO-dependent, was not affected by either pharmacological or genetic disruptions of endothelial caveolae. Acetylcholine-induced relaxation has been shown to be decreased after membrane cholesterol depletion in different rat arteries [38, 39] , but either increased or not modified in systemic arteries isolated from
Cav-1 KO mice [34, 36, 37] . These differences are currently unexplained. Our results highlight the fact that the role of caveolae in NO-dependent relaxant responses may vary from one vascular bed to another. They also suggest that in mouse pulmonary artery, the endothelial muscarinic receptor regulates a pool of eNOS which is not necessarily controlled by caveolin-1.
Conclusions
To conclude, our current study indicates that the mouse pulmonary endothelial β 2 -AR is coupled to a G i/o -Src kinase-PI3K/Akt pathway to promote eNOS phosphorylation at Ser 1177 leading to a NO-dependent vasorelaxation, and that caveolin-1 exerts a negative control on this response, which is removed by its phosphorylation at Tyr 14 through a G i/o -Src kinase pathway (Fig. 7) . In addition, our data clearly show that the mouse pulmonary endothelial β 2 -and muscarinic-receptors activate eNOS through distinct signaling pathways, which differ especially in their dependence on caveolin-1. This further supports the concept that mechanisms underlying eNOS activation are key determinants of pulmonary endothelial dysfunction and may explain why, unlike the muscarinic relaxation, the β 2 -adrenergic relaxation is preserved in pulmonary arteries isolated from mice subjected to chronic hypoxia [6] . 
